(SNEX) Stonex - Overview
Stock: Commodity, Forex, Precious, Metals, Trading, Payments
| Risk 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Relative Tail Risk | -3.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.26 |
| Alpha | 41.88 |
| Character TTM | |
|---|---|
| Beta | 1.029 |
| Beta Downside | 1.217 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.07% |
| CAGR/Max DD | 1.66 |
EPS (Earnings per Share)
Revenue
Description: SNEX Stonex January 08, 2026
StoneX Group Inc. (NASDAQ: SNEX) is a diversified global financial-services firm that links corporates, institutional investors, retail traders and payment processors to markets across the United States, Europe, Latin America, the Middle East and Asia.
The business is organized into four operating segments: Commercial (risk-management, voice brokerage, physical commodity trading, financing and fixed-income dealing), Institutional (execution and clearing of exchange-traded and OTC products), Self-Directed/Retail (FX, precious-metals, CFDs, spread betting and bullion sales via Stonexbullion.com) and Payments (cross-border settlement services).
StoneX, originally founded in 1924 as INTL FCStone, rebranded in July 2020. In FY 2023 the company reported revenue of roughly $2.6 billion and an adjusted EBITDA margin near 13 %, reflecting strong fee income from its commercial hedging and FX businesses.
Key drivers for StoneX include global commodity price cycles (which boost physical trading volumes), central-bank policy shifts that affect FX volatility, and the ongoing growth of electronic retail trading platforms. The firm’s exposure to both physical and derivative markets gives it a diversified revenue base, but also makes earnings sensitive to macro-economic shocks such as sudden commodity price swings or abrupt changes in interest-rate expectations.
For a deeper quantitative look, you might explore ValueRay’s detailed SNEX valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 359.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 8.08 > 1.0 |
| NWC/Revenue: 9.18% < 20% (prev 8.41%; Δ 0.77% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.62b > Net Income 359.8m |
| Net Debt (-1.59b) to EBITDA (2.20b): -0.72 < 3 |
| Current Ratio: 341.4 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.7m) vs 12m ago 10.25% < -2% |
| Gross Margin: 2.01% > 18% (prev 0.02%; Δ 198.6% > 0.5%) |
| Asset Turnover: 370.9% > 50% (prev 365.9%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 1.29 > 6 (EBITDA TTM 2.20b / Interest Expense TTM 1.65b) |
Altman Z'' 2.34
| A: 0.28 (Total Current Assets 13.21b - Total Current Liabilities 38.7m) / Total Assets 47.78b |
| B: 0.04 (Retained Earnings 1.83b / Total Assets 47.78b) |
| C: 0.05 (EBIT TTM 2.12b / Avg Total Assets 38.68b) |
| D: 0.04 (Book Value of Equity 1.82b / Total Liabilities 45.26b) |
| Altman-Z'' Score: 2.34 = BBB |
Beneish M -1.87
| DSRI: 0.87 (Receivables 10.24b/8.90b, Revenue 143.47b/108.25b) |
| GMI: 0.98 (GM 2.01% / 1.97%) |
| AQI: 2.88 (AQ_t 0.72 / AQ_t-1 0.25) |
| SGI: 1.33 (Revenue 143.47b / 108.25b) |
| TATA: -0.07 (NI 359.8m - CFO 3.62b) / TA 47.78b) |
| Beneish M-Score: -1.87 (Cap -4..+1) = B |
What is the price of SNEX shares?
Over the past week, the price has changed by +10.04%, over one month by +19.94%, over three months by +38.79% and over the past year by +59.05%.
Is SNEX a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SNEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135 | 8% |
| Analysts Target Price | 135 | 8% |
| ValueRay Target Price | 175.2 | 40.2% |
SNEX Fundamental Data Overview February 12, 2026
P/S = 0.0472
P/B = 2.6502
Revenue TTM = 143.47b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.20b USD
Long Term Debt = 19.55b USD (from longTermDebt, last quarter)
Short Term Debt = 488.8m USD (from shortLongTermDebt, last quarter)
Debt = 18.52b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -1.59b USD (from netDebt column, last quarter)
Enterprise Value = 23.61b USD (6.69b + Debt 18.52b - CCE 1.59b)
Interest Coverage Ratio = 1.29 (Ebit TTM 2.12b / Interest Expense TTM 1.65b)
EV/FCF = 6.64x (Enterprise Value 23.61b / FCF TTM 3.55b)
FCF Yield = 15.05% (FCF TTM 3.55b / Enterprise Value 23.61b)
FCF Margin = 2.48% (FCF TTM 3.55b / Revenue TTM 143.47b)
Net Margin = 0.25% (Net Income TTM 359.8m / Revenue TTM 143.47b)
Gross Margin = 2.01% ((Revenue TTM 143.47b - Cost of Revenue TTM 140.60b) / Revenue TTM)
Gross Margin QoQ = 2.29% (prev 2.27%)
Tobins Q-Ratio = 0.49 (Enterprise Value 23.61b / Total Assets 47.78b)
Interest Expense / Debt = 2.64% (Interest Expense 488.0m / Debt 18.52b)
Taxrate = 24.82% (45.9m / 184.9m)
NOPAT = 1.60b (EBIT 2.12b * (1 - 24.82%))
Current Ratio = 341.4 (out of range, set to none) (Total Current Assets 13.21b / Total Current Liabilities 38.7m)
Debt / Equity = 7.34 (Debt 18.52b / totalStockholderEquity, last quarter 2.52b)
Debt / EBITDA = -0.72 (Net Debt -1.59b / EBITDA 2.20b)
Debt / FCF = -0.45 (Net Debt -1.59b / FCF TTM 3.55b)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.93% (Net Income 359.8m / Total Assets 47.78b)
RoE = 16.43% (Net Income TTM 359.8m / Total Stockholder Equity 2.19b)
RoCE = 9.77% (EBIT 2.12b / Capital Employed (Equity 2.19b + L.T.Debt 19.55b))
RoIC = 8.24% (NOPAT 1.60b / Invested Capital 19.36b)
WACC = 4.03% (E(6.69b)/V(25.21b) * Re(9.71%) + D(18.52b)/V(25.21b) * Rd(2.64%) * (1-Tc(0.25)))
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.98%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈3.55b ; Y1≈2.33b ; Y5≈1.06b
Fair Price DCF = 676.9 (EV 33.92b - Net Debt -1.59b = Equity 35.51b / Shares 52.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -69.71 | EPS CAGR: -5.66% | SUE: 3.74 | # QB: 1
Revenue Correlation: 90.17 | Revenue CAGR: 26.05% | SUE: 1.54 | # QB: 10
EPS next Quarter (2026-03-31): EPS=2.02 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=8.31 | Chg30d=+0.780 | Revisions Net=+1 | Growth EPS=+38.0% | Growth Revenue=+0.0%
EPS next Year (2027-09-30): EPS=8.78 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+5.7% | Growth Revenue=+0.0%